Multidisciplinary Management of Lateral Skull Base Paragangliomas: A 20-Year Experience
Journal of Neurological Surgery Part B: Skull Base · 01.12.2024 · 85 (06) · 628-634
DOI: 10.1055/a-2158-5781 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurological Surgery Part B: Skull Base, erschienen am 01.12.2024. Verfasst von Eoin F Cleere und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology Head and Neck Surgery, Beaumont Hospital, Dublin, Ireland. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objectives
Paragangliomas of the lateral skull base are rare, largely benign, neuroendocrine tumors. Little evidence exists to support clinicians in the management of these tumors. The present study evaluates considerations in the multidisciplinary workup and management of paragangliomas affecting the lateral skull base.
Methods
A STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) checklist compliant retrospective review of adult patients with lateral skull base paragangliomas over 20 years (2002–2021) was performed. Patient and tumor data were collected from patient health care records.
Results
Seventy patients were identified including 21 (30.0%) males and 49 (70.0%) females. The mean length of follow-up was 87.3 months (range: 12–239 months). Twenty-nine (41.4%) patients had Fisch A or B tumors. Overall, 57 patients (81.4%) were offered treatment upfront, with 13 patients (18.6%) initially undergoing active surveillance. Younger age and reduced American Society of Anesthesiologists (ASA) grade was significantly associated with a decision to offer treatment at presentation (both p = 0.03), while all patients with succinate dehydrogenase (SDH) mutations (n = 10) and tumor secretion (n = 4) were offered treatment. Patients with Fisch A/B tumors (p = 0.01), cranial neuropathies (p = 0.01), and smaller tumors (p = 0.01) were more likely to undergo surgical resection. At the time of the last follow-up, the proportion of patients with a cranial neuropathy was notably lower in the observation (3/12, 25.0%) and radiotherapy (1/6, 16.7%) groups.
Conclusion
In our series, younger, fitter patients with SDH mutations, cranial neuropathies, or tumor secretion were more likely to be offered upfront treatment. There was a low incidence of new cranial neuropathy in the patients selected for observation during long-term follow-up.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology Head and Neck Surgery, Beaumont Hospital, Dublin, Ireland.
- St. Luke's Radiation Oncology Network, Beaumont Hospital Centre, Dublin, Ireland.
- Royal College of Surgeons in Ireland, Dublin, Ireland.
- Department of Radiology, Beaumont Hospital, Dublin, Ireland.
- Department of Neurosurgery, Beaumont Hospital, Dublin, Ireland.
ORCID-Profile: Eoin F Cleere
Zitieren
APA
Cleere, E. F., Mc Loughlin, L., McArdle, O., Fitzpatrick, D., Looby, S., Rawluk, D., Javadpour, M., & McConn-Walsh, R. (2024). Multidisciplinary Management of Lateral Skull Base Paragangliomas: A 20-Year Experience. Journal of Neurological Surgery Part B: Skull Base, 85(06), 628-634. https://doi.org/10.1055/a-2158-5781
Vancouver
Cleere EF, Mc Loughlin L, McArdle O, Fitzpatrick D, Looby S, Rawluk D, et al. Multidisciplinary Management of Lateral Skull Base Paragangliomas: A 20-Year Experience. Journal of Neurological Surgery Part B: Skull Base. 2024;85(06):628-634. doi:10.1055/a-2158-5781
BibTeX
@article{Cleere2024,
author = {Cleere, Eoin F and Mc Loughlin, Laura and McArdle, Orla and Fitzpatrick, David and Looby, Seamus and Rawluk, D and Javadpour, Mohsen and McConn-Walsh, Rory},
title = {Multidisciplinary Management of Lateral Skull Base Paragangliomas: A 20-Year Experience},
journal = {Journal of Neurological Surgery Part B: Skull Base},
year = {2024},
volume = {85},
number = {06},
pages = {628--634},
doi = {10.1055/a-2158-5781}
}
EUVIMED